2023
-
Poster Spotlight Session 12: Putting Brakes on the Cell Cycle: Understanding Mechanisms Governing CDK 4/6 inhibitor Resistance and Role for Novel Therapeutic Strategies – Presenter Profile
Barbara Pistilli, MD, discusses a Thursday morning poster presentation analyzing the CAPItello-292 Phase 1b trial.
-
Rapid-fire Session 2: Mini-Oral Presentations – Presenter Profiles
Amy Tiersten, MD, and Akihiko Shimomura, MD, PhD, discuss their Thursday poster presentations.
-
Social determinants of health must be addressed to improve patient outcomes
On Tuesday, December 5, panelists discussed how cancer outcomes can be adversely affected by environmental, social, cultural, psychological, clinical, biological, genetic, and behavioral factors.
-
SABCS® Daily Highlights for Wednesday, December 6
SABCS® Co-Director Carlos Arteaga, MD, shares a few highlights from Wednesday’s schedule to help you plan your day, including cutting-edge oral and poster presentations, interactive educational sessions, and more.
-
Wednesday General Session and Poster Spotlight Session presentations
Don’t miss Wednesday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
-
Panel discussion to explore frontier of breast cancer immunotherapy
Sherene Loi, MD, PhD, will moderate a Wednesday afternoon State-of-the-Art Session on purpose, resistance, and toxicity of immunotherapeutic approaches in breast cancer.
-
Controversies in Locoregional Care – Presenter Profile
Icro Meattini, MD, discusses a Wednesday afternoon presentation on patient-friendly radiation courses with whole breast and partial breast irradiation.
-
Poster Spotlight Session 7: Prevention – Presenter Profile
Davide Serrano, MD, discusses a Wednesday evening poster presentation on exemestane and breast cancer prevention.
-
Poster Spotlight Session 8: Antibody Drug Conjugates: Where are We Headed? – Presenter Profiles
Francois Poumeaud, MD, and Paolo Tarantino, MD, discuss their Wednesday evening poster presentations.
-
Poster Spotlight Session 9: Exploiting Tumor Biology in HER2-positive Breast Cancer to Escalate or De-escalate Neoadjuvant Therapy – Presenter Profile
Maggie Chon U Cheang, PhD, discusses a Wednesday evening poster presentation on genomic characterization of endocrine resistance in ER+HER2+ breast cancers in the POETIC Trial.